Wyeth Wins Los Angeles Diet Drug Trial
"We are pleased with the verdicts and believe they were supported by the facts. Wyeth will continue to vigorously defend itself in this litigation," says Lawrence V. Stein, Senior Vice President and General Counsel, Wyeth.
The trial began on October 21, 2005 before The Honorable Daniel S. Pratt. The plaintiffs alleged heart valve injury from the use of the diet drug Pondimin, a drug once marketed by Wyeth. In accordance with procedures established by the Court, three of these four plaintiffs were selected for this trial group by plaintiffs' counsel. The plaintiffs were represented by the firms of Williams & Bailey and Blizzard, McCarthy & Nabers of Houston, Texas.
Most read news
Organizations
Other news from the department politics & laws
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.